Results 311 to 320 of about 9,580,811 (383)

The Clinical Impact of Thoracic Endovascular Aortic Repair in the Management of Thoracic Aortic Diseases. [PDF]

open access: yesJ Endovasc Ther
Molano F   +10 more
europepmc   +1 more source

Male-female differences in quality of life and coping style in patients with Marfan syndrome and hereditary thoracic aortic diseases. [PDF]

open access: yesJ Genet Couns, 2020
Thijssen CGE   +9 more
europepmc   +1 more source

Real Time Hemodynamic Monitoring During M‐TEER Using Electrical Cardiometry

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Mitral regurgitation is a common valvular dysfunction causing patient morbidity and mortality. Mitral transcatheter edge‐to‐edge repair (M‐TEER) allows grasping of valvular leaflets and approximation via a small implant, thus reducing mitral regurgitation (MR).
Andreas Goldschmied   +6 more
wiley   +1 more source

Safety and Efficacy of a Plug‐Based Vascular Closure Device After Percutaneous Microaxial Flow Pump in the Treatment of Complex and High‐Risk Indicated Patients

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Femoral large‐bore vascular access is an important and constantly increasing technique in interventional treatment. Temporary circulatory support in complex and high‐risk indicated patients (CHIP) presents a challenge in terms of postinterventional access site closure.
Jörg W. Schröder   +10 more
wiley   +1 more source

Impact of Elevated Preprocedural Left Ventricular Filling Pressure on Prognosis of Mild Paravalvular Regurgitation Following Transcatheter Aortic Valve Replacement

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Paravalvular regurgitation (PVR) following transcatheter aortic valve replacement (TAVR) is a complication linked to poor outcomes. The prognostic impact of mild PVR, particularly in patients with elevated preprocedural left ventricular (LV) filling pressure, remains uncertain.
Shumpei Kosugi   +12 more
wiley   +1 more source

PCSK‐9 Inhibitors Can Significantly Improve the Coronary Slow Flow Caused by Elevated Lipoprotein (a) in ST‐Elevation Myocardial Infarction Patients With Chronic Kidney Disease

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Coronary slow flow and no reflow significantly predict poor prognosis in acute myocardial infarction (AMI) patients, especially those with chronic kidney disease (CKD). Early identification of factors contributing to these conditions can mitigate ischemic events and improve outcomes.
Hao Xu   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy